Omega Fund Management, LLC Long-Term Concentrated

Location: Boston, MA

CIK: 0001637359 · Show all filings

Period: Q3 2024 (← Previous) (Next →)

Filing Date: Nov 14, 2024

Total Value: $160M (100.0% shares, 0.0% debt)

Holdings (11)

BCAX Bicara Therapeutics Inc. 35.1%

Value $56.15M Shares 2,204,650 Est. Cost $25.50 Unrealized 0.0%

NUVB Nuvation Bio 18.7%

Value $29.94M Shares 13,072,340 Est. Cost $11.18 Unrealized -72.7%

REPL Replimune Group 16.9%

Value $26.98M Shares 2,461,319 Est. Cost $17.40 Unrealized -41.6%

LXEO Lexeo Therapeutics 13.3%

Value $21.3M Shares 2,355,904 Est. Cost $12.69 Unrealized -6.0%

ENGN enGene Holdings Inc. 4.4%

Value $7.104M Shares 1,076,357 Est. Cost $10.40 Unrealized -28.5%

ALMS Alumis Inc 4.4%

Value $6.976M Shares 653,223 Est. Cost $13.30 Unrealized -8.8%

— Ikena Oncology 2.4%

Value $3.891M Shares 2,249,123 Est. Cost $28.25 Unrealized —

SANA Sana Biotechnology, Inc. 2.2%

Value $3.51M Shares 843,750 Est. Cost $32.56 Unrealized -83.9%

IMUX Immunic Inc 1.8%

Value $2.95M Shares 1,788,160 Est. Cost $13.89 Unrealized -89.8%

ENGNW enGene Holdings Inc. 0.4%

Value $675K Shares 321,502 Est. Cost $0.85 Unrealized —

SYRS Syros Pharmaceuticals 0.3%

Value $540K Shares 251,270 Est. Cost $8.12 Unrealized -55.8%

Ticker	Issuer	Shares	Value	%	Est. Cost	Unrealized	Class	CUSIP
BCAX	Bicara Therapeutics Inc.	2,204,650	$56.15M	35.1%	$25.50	0.0%	Common Stock	055477103
NUVB	Nuvation Bio	13,072,340	$29.94M	18.7%	$11.18	-72.7%	Common Stock Class A	67080N101
REPL	Replimune Group	2,461,319	$26.98M	16.9%	$17.40	-41.6%	Common Stock	76029N106
LXEO	Lexeo Therapeutics	2,355,904	$21.3M	13.3%	$12.69	-6.0%	Common Stock	52886X107
ENGN	enGene Holdings Inc.	1,076,357	$7.104M	4.4%	$10.40	-28.5%	Common Stock	29286M105
ALMS	Alumis Inc	653,223	$6.976M	4.4%	$13.30	-8.8%	Common Stock	022307102
—	Ikena Oncology	2,249,123	$3.891M	2.4%	$28.25	—	Common Stock	45175G108
SANA	Sana Biotechnology, Inc.	843,750	$3.51M	2.2%	$32.56	-83.9%	Common Stock	799566104
IMUX	Immunic Inc	1,788,160	$2.95M	1.8%	$13.89	-89.8%	Common Stock	4525EP101
ENGNW	enGene Holdings Inc.	321,502	$675K	0.4%	$0.85	—	Warrant	29286M113
SYRS	Syros Pharmaceuticals	251,270	$540K	0.3%	$8.12	-55.8%	Common Stock	87184Q206